OrganiGram Holdings (OrganiGram Holdings) Debt-to-Equity : 0.00 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is OrganiGram Holdings Debt-to-Equity?

OrganiGram Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.05 Mil. OrganiGram Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.04 Mil. OrganiGram Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $200.80 Mil. OrganiGram Holdings's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for OrganiGram Holdings's Debt-to-Equity or its related term are showing as below:

During the past 10 years, the highest Debt-to-Equity Ratio of OrganiGram Holdings was 0.69. The lowest was -0.01. And the median was 0.20.

OGI's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

OrganiGram Holdings Debt-to-Equity Historical Data

The historical data trend for OrganiGram Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganiGram Holdings Debt-to-Equity Chart

OrganiGram Holdings Annual Data

Trend

Apr12

Apr13

Apr14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Debt-to-Equity

Get a 7-Day Free Trial

0.04

0.54

0.15

0.39

0.01

OrganiGram Holdings Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of OrganiGram Holdings's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, OrganiGram Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OrganiGram Holdings's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OrganiGram Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where OrganiGram Holdings's Debt-to-Equity falls into.

OrganiGram Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

OrganiGram Holdings's Debt to Equity Ratio for the fiscal year that ended in Aug. 2021 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.845	+	3.874)	/	380.828
	=	0.01

OrganiGram Holdings's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.049	+	0.038)	/	200.796
	=	0.00

OrganiGram Holdings (NAS:OGI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

OrganiGram Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

OrganiGram Holdings (OrganiGram Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (NAS:OGI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

0OG0:Germany 0OG0:Germany OGI:Canada

Address

145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8

Website

https://www.organigram.ca

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.